نتایج جستجو برای: grade adenocarcinoma

تعداد نتایج: 223137  

2009
Ruchi Gupta Kirti Gupta Rijuneeta Gupta

INTRODUCTION Polymorphous low-grade adenocarcinoma is a distinct neoplasm of the salivary gland composed of luminal and non-luminal tumor cells admixed in varying proportions. Its resemblance to lobular carcinoma of the breast had led to its earlier nomenclature of 'terminal duct carcinoma'. Most patients present with an asymptomatic mass in the hard palate. In rare cases, the mass can also occ...

Journal: :Turk patoloji dergisi 2012
Hülya Tosun Yildirim Nilay Sentürk

OBJECTIVE Prostate cancer is the second most common cause of male cancer deaths after lung cancer in developed countries. The prognostic factors currently identified for prostate carcinoma include preoperative serum PSA, TNM staging system, histological grade and surgical margin status and are composed of the clinically most important and useful parameters. However, all the markers studied have...

Journal: :The Journal of pathology 1995
K K Krishnadath H W Tilanus M van Blankenstein F T Bosman A H Mulder

Accumulation of p53 protein was determined by immunohistochemistry in archival material of biopsy specimens from 102 patients with Barrett's oesophagus with different grades of dysplasia, in 24 oesophageal adenocarcinomas associated with Barrett's oesophagus, and in 23 cases of metaplastic epithelium adjacent to these carcinomas. Immunostaining for the p53 protein was found in 23/102 (23 per ce...

Journal: :Journal of Oral and Maxillofacial Pathology 2015

2013
Yasuhiro Sakai Takashi Yamasaki Yoshito Kusakabe Daisuke Kasai Yoshikazu Kotani Yoshihiro Nishimura Tomoo Itoh

PURPOSE A high rate of response to treatment with epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) has been observed in certain patients (women, of East Asian ethnicity, with non-smoking history and adenocarcinoma histology) with mutations in exons 18 to 21 of the tyrosine kinase domain of EGFR. Some cases of high-grade neuroendocrine carcinoma of the lung harboring mutatio...

Journal: :Neoplasma 2012
L Xing H Lu J Zhang J Yu F Wang X Yu H Yu L Xia

This phase I study is designed to determine the maximal tolerated dose and the dose-limiting toxicity of docetaxel with cisplatin and concurrent radiotherapy in patients with unresectable locally advanced gastric adenocarcinoma. Docetaxel was given once a week with the dosage escalated from 5 mg/m(2) to 15 mg/m(2) in increments of 2.5 mg/m(2). Cisplatin were administered at 20 mg/m(2) once a we...

Journal: :Tzu Chi Medical Journal 2019

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید